{"id":2116,"date":"2021-09-02T17:17:36","date_gmt":"2021-09-02T21:17:36","guid":{"rendered":"https:\/\/lifescivoice.com\/?p=2116"},"modified":"2021-09-03T01:29:01","modified_gmt":"2021-09-03T05:29:01","slug":"china-based-lynk-pharmaceuticals-raises-50m-in-series-b-funding-round","status":"publish","type":"post","link":"https:\/\/lifescivoice.com\/china-based-lynk-pharmaceuticals-raises-50m-in-series-b-funding-round\/","title":{"rendered":"China based Lynk Pharma raises $50M in series B funding round"},"content":{"rendered":"\n<p>The <a href=\"https:\/\/lifescivoice.com\/\">Chinese pharmaceutica<\/a>l R&amp;D company, Lynk Pharmaceuticals Co. Ltd., has successfully raised $50 million in Series B funding round.<\/p>\n\n\n\n<p>It was founded in 2018 by the Chairperson and CEO, Dr. Zhao-Kui (ZK) Wan, with the aim to develop FIC\/BIC small molecule drugs globally for different cancers, autoimmune and inflammatory diseases.<\/p>\n\n\n\n<p>Within the three and half years of its existence, the pharmaceutical <a href=\"https:\/\/lifescivoice.com\/\">R&amp;D company<\/a> has managed to receive IND approvals in China and U.S. for three of its products, initiated worldwide clinical development efforts and completed ex-Chinese rights out-license of LNK01001 to a U.S. company and also in-license of the top-tier RAS program of Japan\u2019s Kobe\u00a0University and RIKEN in 2020. \u00a0<\/p>\n\n\n\n<p>The Series B financing round was headed by Lilly Asia Ventures (LAV) as a lead investor. New Alliance Capital and Hangzhou HEDA Biological Medicine Venture Capital Partnership (L.L.P.), together with its original shareholders Legend Capital and Med-Fine Capital, also took part for the cause. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p>The company now plans to utilize these funds for phase I and II clinical trials of certain projects in its R&amp;D pipeline. Moreover, these funds will be used for extending international business of the company Lynk Pharmaceuticals upholding international collaborations with various companies and aiding <a href=\"https:\/\/lifescivoice.com\/\">preclinical developmen<\/a>t of new projects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Chinese pharmaceutical R&amp;D company, Lynk Pharmaceuticals Co. Ltd., has successfully raised $50 million in Series B funding round. It was founded in 2018 by the Chairperson and CEO, Dr. Zhao-Kui (ZK) Wan, with the aim to develop FIC\/BIC small molecule drugs globally for different cancers, autoimmune and inflammatory diseases. Within the three and half [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2138,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[115,517],"class_list":{"0":"post-2116","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-research-development","8":"tag-china","9":"tag-lynk-pharmaceuticals"},"_links":{"self":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts\/2116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/comments?post=2116"}],"version-history":[{"count":0,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts\/2116\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/media\/2138"}],"wp:attachment":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/media?parent=2116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/categories?post=2116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/tags?post=2116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}